Phenotypic and functional characteristics of CD4+CD39+ FOXP3+ and CD4+CD39+FOXP3neg T-cell subsets in cancer patients

European Journal of Immunology

Volumn 42, Issue 7, 2012, Pages 1876-1885

  Schuler, Patrick J ^a,b   Schilling, Bastian ^a   Harasymczuk, Malgorzata ^a   Hoffmann, Thomas K ^b   Johnson, Jonas ^a   Lang, Stephan ^b   Whiteside, Theresa L ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

ATP hydrolysis; CD39 expression; CD4+CD39+ Treg cells; Head and neck squamous cell cancer (HNSCC); Immune suppression

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CD39 ANTIGEN; CD4 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; GLYCOPROTEIN A REPETITIONS PREDOMINANT; INTERLEUKIN 1 RECEPTOR TYPE I; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; LATENCY ASSOCIATED PEPTIDE; PROGRAMMED DEATH 1 RECEPTOR; PROTEIN; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CANCER PATIENT; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; LUMINESCENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

ADENOSINE; ADENOSINE TRIPHOSPHATE; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CTLA-4 ANTIGEN; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HEAD AND NECK NEOPLASMS; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PROGRAMMED CELL DEATH 1 RECEPTOR; RECEPTORS, INTERLEUKIN-1 TYPE I; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 84864005209     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201142347     Document Type: Article

References (23)

1. Strauss, L., Bergmann, C., Gooding, W., Johnson, J. T. and Whiteside, T. L., The frequency and suppressor function of CD4+CD25highFoxp3+ T cells in the circulation of patients with squamous cell carcinoma of the head and neck. Clin. Cancer Res. 2007. 13: 6301-6311.
2. Kryczek, I., Wu, K., Zhao, E., Wei, S., Vatan, L., Szeliga, W., Huang, E. et al., IL-17+ regulatory T cells in the microenvironments of chronic inflammation and cancer. J. Immunol. 2011. 186: 4388-4395.
3. Gounaris, E., Blatner, N. R., Dennis, K., Magnusson, F., Gurish, M. F., Strom, T. B., Beckhove, P. et al., T-regulatory cells shift from a protective anti-inflammatory to a cancer-promoting proinflammatory phenotype in polyposis. Cancer Res. 2009. 69: 5490-5497.
4. Sakaguchi, S., Miyara, M., Costantino, C. M. and Hafler, D. A., FOXP3+ regulatory T cells in the human immune system. Nat. Rev. Immunol. 2010. 10: 490-500.
5. Sakaguchi, S., Wing, K., Onishi, Y., Prieto-Martin, P. andYamaguchi, T., Regulatory T cells: how do they suppress immune responses? Int. Immunol. 2009. 21: 1105-1111.
6. Bindea, G., Mlecnik, B., Fridman, W. H. and Galon, J., The prognostic impact of anti-cancer immune response: a novel classification of cancer patients. Semin. Immunopathol. 2011. 33: 335-340.
7. Bergmann, C., Strauss, L., Zeidler, R., Lang, S. and Whiteside, T. L., Expansion of human T regulatory type 1 cells in the microenvironment of cyclooxygenase 2 overexpressing head and neck squamous cell carcinoma. Cancer Res. 2007. 67: 8865-8873.
8. Zhou, X., Bailey-Bucktrout, S., Jeker, L. T. and Bluestone, J. A., Plasticity of CD4(+) FoxP3(+) T cells. Curr. Opin. Immunol. 2009. 21: 281-285.
9. Borsellino, G., Kleinewietfeld, M., Di Mitri, D., Sternjak, A., Diamantini, A., Giometto, R., Hopner, S. et al., Expression of ectonucleotidase CD39 by Foxp3+ Treg cells cells: hydrolysis of extracellular ATP and immune suppression. Blood 2007. 110: 1225-1232.
10. Deaglio, S., Dwyer, K. M., Gao, W., Friedman, D., Usheva, A., Erat, A., Chen, J. F. et al., Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med. 2007. 204: 1257-1265.
11. Dwyer, K. M., Hanidziar, D., Putheti, P., Hill, P. A., Pommey, S., McRae, J. L., Winterhalter, A. et al., Expression of CD39 by human peripheral blood CD4+ CD25+ T cells denotes a regulatory memory phenotype. Am. J. Transplant. 2010. 10: 2410-2420.
12. Schuler, P. J., Harasymczuk, M., Schilling, B., Lang, S. and Whiteside, T. L., Separation of human CD4+CD39+ T cells by magnetic beads reveals two phenotypically and functionally different subsets. J. Immunol. Methods 2011. 369: 59-68.
13. Moncrieffe, H., Nistala, K., Kamhieh, Y., Evans, J., Eddaoudi, A., Eaton, S. andWedderburn, L. R., High expression of the ectonucleotidase CD39 on T cells from the inflamed site identifies two distinct populations, one regulatory and one memory T-cell population. J. Immunol. 2010. 185: 134-143.
14. Zhou, L., Chong, M. M. and Littman, D. R., Plasticity of CD4 + T-cell lineage differentiation. Immunity 2009. 30: 646-655.
15. Ndhlovu, L. C., Leal, F. E., Eccles-James, I. G., Jha, A. R., Lanteri, M., Norris, P. J., Barbour, J. D. et al., A novel human CD4+ T-cell inducer subset with potent immunostimulatory properties. Eur. J. Immunol. 2010. 40: 134-141.
16. Schenk, U., Frascoli, M., Proietti, M., Geffers, R., Traggiai, E., Buer, J., Ricordi, C. et al., ATP inhibits the generation and function of regulatory T cells through the activation of purinergic P2X receptors. Sci. Signal 2011. 4: ra12.
17. Ohta, A. and Sitkovsky, M., Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 2001. 414: 916-920.
18. Whiteside, T. L., Mandapathil, M. andSchuler, P., The role of the adenosinergic pathway in immunosuppression mediated by human regulatory T cells (Treg cells). Curr. Med. Chem. 2011. 18: 5217-5223.
19. Zhou, X., Bailey-Bucktrout, S. L., Jeker, L. T., Penaranda, C., Martinez-Llordella, M., Ashby, M., Nakayama, M. et al., Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat. Immunol. 2009. 10: 1000-1007.
20. Bailey-Bucktrout, S. L. and Bluestone, J. A., Regulatory T cells: stability revisited. Trends Immunol. 2011. 32: 301-306.
21. Kryczek, I., Zhao, E., Liu, Y., Wang, Y., Vatan, L., Szeliga, W., Moyer, J. et al., Human TH17 cells are long-lived effector memory cells. Sci. Transl. Med. 2011. 3: 104ra100.
22. Schulze Zur Wiesch, J., Thomssen, A., Hartjen, P., Toth, I., Lehmann, C., Meyer-Olson, D., Colberg, K. et al., Comprehensive analysis of frequency and phenotype of T regulatory cells in HIV infection: CD39 expression of FoxP3+ T regulatory cells correlates with progressive disease. J. Virol. 2011. 85: 1287-1297.
23. Law, J. P., Hirschkorn, D. F., Owen, R. E., Biswas, H. H., Norris, P. J. and Lanteri, M. C., The importance of Foxp3 antibody and fixation/permeabilization buffer combinations in identifying CD4+CD25+Foxp3+ regulatory T cells. Cytometry A. 2009. 75: 1040-1050.